Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia

NCT07494916 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-03-27

No results posted yet for this study

Summary

Sarcopenia is a condition associated with aging that causes a loss of muscle mass, strength, and physical function. This decline limits the ability to perform basic daily activities and increases the risk of falls and dependency.

The purpose of this clinical study is to determine the effects of a 12-week Functional Task Training (FTT) program on functional, structural, and physiological biomarkers in older adults with sarcopenia. FTT involves practicing everyday movements, such as standing up from a chair, climbing stairs, walking, and carrying objects.

The study aims to answer the following question: Does Functional Task Training performed specifically in optimal muscle power zones offer greater improvements in aging biomarkers compared to standard Functional Task Training or traditional resistance training?

The researchers hypothesize that while all exercise interventions will be beneficial, the FTT program focused on power zones will generate the greatest improvements in functional, physiological, and structural biomarkers in older adults with sarcopenia.

To test this, 30 older adults (aged 60 and older) will be randomly assigned to one of three active groups for a 12-week period (2 days per week): an FTT group training in power zones, a standard FTT group, or a traditional resistance training group. All exercise groups will use a Functional Electromechanical Dynamometer (DEMF) to precisely measure and control the training loads.

Conditions

  • Sarcopenia
  • Aging
  • Physical Functional Performance
  • Muscle Weakness | Patient

Interventions

BEHAVIORAL

Functional Task Training in Power Zones

Participants will perform a 12-week Functional Task Training (FTT) program (2 sessions/week, 60 min/session). The circuit includes 4 specific functional tasks designed to simulate daily life demands: 1) Sit-to-stand from a chair, 2) Walking with changes of direction, 3) Lifting and carrying objects, and 4) Pulling/pushing movements. All exercises will be executed using a Functional Electromechanical Dynamometer (DEMF). This device provides constant electronic resistance and allows for the determination of the individual load that elicits peak power output. Training intensity will be strictly monitored to ensure participants perform each repetition within their optimal muscle power zone. Loads will be adjusted progressively (5-10% weekly) based on the velocity and power data provided by the device. Each session includes a warm-up, 3 sets of 10-12 repetitions per task, and a cool-down.

BEHAVIORAL

Standard Functional Task Training

Participants will perform a 12-week Functional Task Training (FTT) program (2 sessions/week, 60 min/session). The circuit includes 4 specific functional tasks: 1) Sit-to-stand from a chair, 2) Walking with changes of direction, 3) Lifting and carrying objects, and 4) Pulling/pushing movements. All exercises will be executed using the Functional Electromechanical Dynamometer (DEMF). Training follows standard progressive resistance protocols (5-10% weekly load increase) based on individual tolerance, without specifically targeting or monitoring the optimal muscle power zones.

BEHAVIORAL

Traditional Resistance Training

Participants will complete a 12-week traditional resistance training program (2 sessions/week, 60 min/session). The protocol targets major muscle groups through 4 conventional analytical exercises (e.g., leg press, chest press, row, and leg extension). These exercises will be performed using the DEMF device to control and monitor the training loads. This group does not perform functional task simulations or power-zone specific training, following a standard hypertrophy and strength progression.

Sponsors & Collaborators

  • Universidad de Granada

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-02
Primary Completion
2026-05-30
Completion
2027-07-02

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07494916 on ClinicalTrials.gov